<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The systemic metabolic response following intracranial vascular damage was measured in 65 consecutively seen patients (56 with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and nine with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>Significantly (P less than .01) greater mortality and eventual disability occurred in patients excreting more than 200 microgram of urinary <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> and <z:chebi fb="2" ids="28918">epinephrine</z:chebi> daily early in their <z:hpo ids='HP_0011009'>acute</z:hpo> illness </plain></SENT>
<SENT sid="2" pm="."><plain>These patients also had significantly (P less than .001) elevated plasma <z:chebi fb="1" ids="17650">cortisol</z:chebi> levels; this measurement may prove useful in predicting prognosis after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001627'>Cardiac abnormalities</z:hpo> resulting from the elevated <z:chebi fb="2" ids="33567">catecholamine</z:chebi> levels may contribute to the excess mortality in those patients with an intense stress response </plain></SENT>
</text></document>